Fundraising FoxSolas BioVentures — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)inJim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)inAllen Meacham(President and Chief Executive Officer)inBrad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)in
Co-investorsFresenius Medical Care Ventures
EirSystems builds medication management infrastructure for healthcare providers and EHR platforms, focusing on electronic medication administration records and opioid prescription monitoring across long-term care, behavioral health, and post-acute settings.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSChattanooga, US
Robert Newman(Executive Officer, Director, Promoter)inRyan Seaberg(Co-Founder)Tyler Seaberg(Executive Officer, Director, Promoter)
Co-investorsAtlanta Technology AngelsChain Reaction
Pathware provides real-time biopsy quality assessment technology for pathologists to determine sample adequacy on-site, reducing repeat procedures and unnecessary surgeries.
AI & Machine LearningHealthtechMedical Devices
Co-investorsCANTILEVER INVESTORSInnoventures IowaNext Level VenturesLevel Eight Ventures
Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions.
AI & Machine LearningDigital HealthHealthtechPlymouth, US
Brian D. Athey(Co-founder)Daniel Jasewicz(Company Leadership (Strategy & Commercialization))inGerry Higgins(Scientific Strategy Lead)inAlex Ade(Technology & Data Science Lead)inPamela Weir(Director)Lew Wallace(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.